Incident Hepatocellular Carcinoma Risk in Patients Treated with a Sulfonylurea: A Nationwide, Nested, Case-Control Study

Several studies have shown that the use of sulfonylureas in patients with type 2 diabetes mellitus (T2DM) is associated with a higher risk of hepatocellular carcinoma (HCC). In this study, we investigated the effects of individual sulfonylureas on HCC development using the National Health Insurance...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Ji-Yeon, Jang, Suk-Yong, Nam, Chung Mo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561966/
https://www.ncbi.nlm.nih.gov/pubmed/31189966
http://dx.doi.org/10.1038/s41598-019-44447-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6561966/
https://www.ncbi.nlm.nih.gov/pubmed/31189966
http://dx.doi.org/10.1038/s41598-019-44447-1

Ejemplares similares